This, together with the current finding that a subset of EMPD tumors showed an upregulated CD8 T cell signature, CD273 (PD-1 gene), and CD274 (PD-L1 gene), suggests that anti-PD-1 therapy is worth considering. This evidence concerns the gene CD8A and extramammary Paget disease.